|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-12-09 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 14-12-09 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| +1.00% | +4.39% | +21.55% | +11.96% | +4.42% | +43.53% | -0.12% | +29.00% | +91.20% | 79.68B | |
| +0.97% | +3.30% | +11.71% | +10.92% | -7.73% | -2.19% | +26.99% | +3.48% | - | 50.61B | |
| -1.22% | -2.62% | -7.00% | -8.36% | -8.17% | +15.13% | +167.13% | +123.21% | +218.83% | 48.81B | |
| +0.17% | +4.23% | +12.05% | +41.66% | -20.20% | -48.99% | -47.61% | -53.69% | +18.49% | 46.91B | |
| +0.85% | +2.12% | +0.78% | +2.99% | +19.69% | +55.82% | -23.03% | -38.45% | -32.90% | 30.86B | |
| -0.03% | +18.18% | -5.01% | +26.24% | +115.84% | +136.71% | -37.28% | -83.67% | - | 25.42B | |
| -0.21% | +1.81% | +5.51% | +21.96% | +22.02% | +40.38% | +82.80% | +64.04% | +48.70% | 24.48B | |
| +0.53% | +1.16% | +6.55% | +10.67% | +25.84% | -0.05% | +196.14% | +32.80% | - | 21.2B | |
| -3.14% | -1.92% | -2.25% | +18.36% | +6.17% | +61.19% | +161.38% | +62.03% | - | 16.39B | |
| +0.85% | +0.63% | -2.73% | +2.28% | +34.80% | +62.89% | +111.21% | +153.88% | +341.97% | 16.18B | |
| 0.00% | +8.18% | +30.41% | +16.60% | -8.18% | -8.07% | +768.95% | +509.98% | +6,202.86% | 15.6B | |
| -2.43% | +11.50% | +15.76% | +27.97% | +15.31% | +17.55% | -23.35% | -8.66% | -25.87% | 13.6B | |
| -0.46% | +1.69% | -6.40% | -9.20% | +17.00% | +95.34% | +207.01% | +834.73% | +2,772.04% | 11.24B | |
| -1.36% | +1.75% | -9.66% | +5.04% | +33.18% | +119.86% | +176.03% | +484.44% | - | 9.85B | |
| +0.06% | +14.86% | +38.67% | +130.35% | +294.99% | +337.31% | +461.59% | +24.65% | - | 7.85B | |
| +0.74% | +0.45% | +13.92% | +15.34% | -5.14% | -19.86% | -22.46% | -50.70% | -48.32% | 6.96B | |
| +0.36% | +13.61% | +18.63% | +32.90% | +13.82% | +22.81% | +83.17% | +2.62% | - | 6.81B | |
| +1.69% | +11.45% | -6.54% | -0.82% | +15.82% | +35.28% | +269.73% | +242.90% | - | 6.22B | |
| -0.41% | +1.73% | +27.72% | +31.65% | +88.68% | +131.29% | +355.15% | +535.87% | - | 6.1B | |
| Average | -0.09% | +4.67% | +8.61% | +20.45% | +34.64% | +57.68% | +153.34% | +150.97% | +958.70% | 22.24B | |
| Weighted average by Cap. | +0.10% | +3.92% | +8.54% | +15.83% | +16.93% | +36.10% | +89.64% | +78.85% | +515.72% |
- Stock Market
- Stocks
- Stock
- Sector Cubist Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
